Our Research and Medical Toxicology Departments can provide a wide range of

    consulting and research services to:

§         Orphan drug companies,

§         Biotechnology companies,

§         Legal firms,

§         Chemical manufacturers,

§         Pharmaceutical companies;

§         Local, state and federal governmental agencies, and

§         Other organizations.

    Services include:

§         Medical research and development services;

§         Adverse event reporting;

§         Clinical toxicology trial design and implementation, including multi-center study coordination and administration;

§         Antidote and orphan drug development and testing;

§         Clinical data management;

§         Toxicological evaluation of medical and scientific literature;

§         Environmental hazard consultation;

§         Occupational exposure consultation, including patient examinations;

§         Chemical and biological terrorism preparedness planning and assessment; and

§         Prescription drug abuse surveillance (RADARS^® System)

    Through its research five antidotes have been developed, including:

§         CroFab® - an Antivenom treatment for patients with North American crotalid (venemous) snake envenomation;

§         Acetadote® - an intravenous treatment for acetaminophen overdose;

§         DigiFab® - treatment for life threatening digoxin toxicity;

§         Antizol® - an antidote for ethylene glycol or methanol ingestions; and

§         Radiogardase® - treatment for known or suspected exposure to radioactive cesium-137 or radioactive or non-radioactive thallium.